Since highly purified human pituitary growth hormone has become available, much information concerning its metabolic effects has been accumulated. However, simple and specific methods of measuring endogenous levels of human growth hormone have been difficult to achieve. Attempts to assay human growth hormone by injecting whole serum into hypophysectomized rats and measuring the width of the tibial plate have generally failed to show any activity in normal serum, although some acromegalic sera have been found to contain stimulating activity (1) (2) (3) . More recently, Gemzell (4) assayed extracts of plasma using the tibial-line assay and found up to 12.3 ,ug growth hormone activity per ml of plasma in acromegalic subjects. Growth hormone-like activity was also found in plasma extracts from certain patients with diabetes, liver disease, and several other conditions; however, no activity was detected in extracts of normal plasma (5) . The variability, insensitivity, and questionable specificity of the tibial assay system have raised doubts as to the significance of these results. In this laboratory, measurement of the serum sulfation factor has proved a useful indicator of growth hormone activity, but it is, nevertheless, not a direct measurement of growth hormone (6) .
Immunologic methods for assaying human growth hormone have recently attracted much attention. Li, Moudgal and Papkoff (7) have been able to detect as little as 2.5 ug of growth hor-* Supported by Research Grant A-1526 from the National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, and by an institutional grant to Washington University from the American Cancer Society. Clinical studies were carried out on the Washington University-Barnard Hospital Clinical Research Center, under support of Grant OG-12, Division of General Medical Sciences, National Institutes of Health. Presented in part before the Fifty-third Annual Meeting of the American Society for Clinical Investigation, Atlantic City, N. J., May, 1961. mone by direct precipitation with specific antiserum -and reported finding approximately 200 m/Ag of growth hormone per ml in acromegalic serum. Greenspan, Cofell, Lew and Peng (8) have increased the sensitivity of the precipitin reaction by the use of radioiodinated antiserum to human growth hormone, so that as little as 1 jug of growth hormone could be detected.
Read and Bryan (9) (11) have achieved this separation by chromatoelectrophoresis in their insulin assay. Another procedure has been immunologic precipitation of the hormone-antibody complex. In their study of sera of diabetic patients containing antibodies that react with heterologous insulin, Skom and Talmage (12) have precipitated insulin-I131 bound to human y-globulin by the ad-dition of antihuman y-globulin serum. Recently, both chromatoelectrophoresis and immunoprecipitation have proved successful in separating soluble glucagon-I'31-antibody complexes from unreacted glucagon-I131 in a sensitive radio-immunoassay (13) .
In this paper, the radioiodination of human growth hormone and utilization of the labeled hormone for a highly sensitive radio-immunoassay are described. In this assay the soluble growth hormone-I131-antibody complex has been precipitated immunologically by the technique of Skom and Talmage.
MATERIALS AND METHODS
Human growth hormone (HGH). HGH was prepared from acetone-dried pituitaries by the Raben method (14) . The final product was lyophilized and kept at 50 C until use. Monkey growth hormone was supplied by Dr. A. E. Wilhelmi. The porcine and bovine hormones were obtained from Dr. Joseph Fisher, Armour Laboratories, Chicago, Ill.
Stock solutions of HGH were prepared in a concentration of 0.2 mg per ml in 0.01 M phosphate -0.15 M NaCl buffer, pH 7.2, and kept at -140 C until use.
Preparation of HGH-I'. HGH has been iodinated in a number of ways. At first, iodination was carried out by a modification of the procedure used by Yalow and Berson (11) for iodinating insulin. In this method, which has been described in detail (15) , iodide is oxidized to molecular iodine in acid solution with nitrous acid. The iodine is then extracted into chloroform and from the chloroform into alkaline solution containing HGH. Although useful preparations were frequently obtained, other preparations proved to be extensively denatured, perhaps due to trace impurities in the chloroform or the initial oxidation mixture.
More recently, HGH has been iodinated by a modification of the distillation procedure used by Staub, Springs and Elrick in the preparation of glucagon-I.3. (16) . Their apparatus was modified by addition of a Y-joint with Teflon stopcocks to allow refluxing and addition of reagents without disconnecting the reaction vessel ( Figure 1 ). To carry out the iodination 10 to 20 mc carrier-free NaI.3. (Union Carbide Nuclear Corp., Oak Ridge, Tenn.), 1.5 ml 2 N H2SO4, and 2.5 ml H20 were added to the distilling flask, refluxed gently for 30 minutes, and allowed to cool. Then 3.0 ml H20 and 0.5 to 0.2 to 1.0 mg HGH in 1.0 ml 0.2 M borate buffer, pH 8.0, in an ice-bath. During the addition of I.3. and for 3 minutes thereafter, the growth hormone was mixed with a small Teflon-covered magnet and a magnetic stirrer. The reaction mixture was next transferred to a cellophane bag, one end of which was tied to a rubber serum-bottle cap, and dialyzed for 2 hours against a continuous flow of 0.15 M NaCi at a rate of 14 L per hour. Bovine serum albumin (Nutritional Biochemicals, Cleveland, Ohio), sufficient to provide a final concentration of 5 per cent, was injected into the bag after 1 hour. After the second hour of continuous flow dialysis, the HGH-111 was dialyzed against 2.5-L volumes of 0.15 M sodium chloride for 16 to 20 hours. The prolonged dialysis was necessary to remove trichloroacetic acid (TCA)-soluble fragments of HGH. The bovine serum albumin (BSA) was added to minimize radiation damage to the hormone (17) and adsorption of the labeled hormone to glassware (18) .
Both iodination procedures have yielded HGH-I1'
with calculated specific activities of up to 5 mc per mg.
These preparations were over 97 per cent precipitable in 7.5 per cent TCA and 75 to 85 per cent precipitable immunologically. This discrepancy between TCA and immune precipitability has been attributed to the presence of nondialyzable TCA-precipitable labeled protein fragments which do not react with anti-HGH serum. Much of this probably represents partially degraded HGH, but the presence of labeled protein contaminants of the Raben HGH has not been completely excluded. After 2 to 3 weeks' storage at 50 C, the concentration of TCA-soluble P"31 increased to 5 to 10 per cent. The calculated I: GH molecular ratios have ranged from 0.25 to 2.0. Preparations made with higher I: GH ratios have been found less reactive with antibody.
The iodinated growth hormone was added to normal human serum and subjected to starch block electrophoresis in a barbital buffer of pH 8.6, ionic strength 0.1, for 18 hours at 250 v. After electrophoresis, imprints were made and stained. Segments of 1 cm width were cut, protein was eluted with water, and aliquots of the eluate were counted in a well-type scintillation counter. In this system nearly all radioactivity migrated as a single component with the mobility of the a-globulins.
Preparation of anti-HGH serum. The antigen was prepared by emulsifying 2.5 mg HGH in 2.5 ml saline and 2.5 ml Ramon's (19) or Freund's (20) adjuvant. This mixture was given subcutaneously to New Zealand white rabbits at weekly intervals for 3 weeks. Two weeks after the final injection the rabbits were bled by cardiac puncture. Because of the possibility of trace contamination with other pituitary hormones or with serum proteins which could serve as effective antigens, it is probably undesirable to give booster injections to the same rabbit.
The double diffusion gel technique of Preer (21) was used to test the specificity of our antihuman growth hormone immune sera. Antigens tested were our preparation of HGH, HGH-I13, human serum albumin (Squibb), human y-globulin (Squibb), and serum from a hypophysectomized patient. Using undiluted anti-HGH antiserum, a single precipitin zone was observed with HGH (10 jg per ml), HGH-1.31 (10 ptg per ml), and with hypophysectomized human serum (diluted 1: 10). No precipitin zone was noted with albumin or y-globulin.
Preparation of antirabbit y-globulin serum (anti-RGG serum). Two injections of 40 mg of rabbit y-globulin (Pentex, Inc., Kankakee, Ill.) in 8 ml of adjuvant were given subcutaneously to adult female goats 6 weeks apart, and 2 months later the animals were bled by jugular puncture.
The goat anti-RGG serum was fractionated by precipitation at 1.4 M (NH4)2SO4, suspension of the precipitin in water, and dialysis against buffered saline, until the dialysant was free of sulfate. All antisera were stored at -140 C until use and then dilutions of the antisera were prepared with 0.01 M phosphate-0.15 M NaCl buffer, pH 7.2.
Titration of goat anti-RGG. A constant volume of goat anti-RGG serum and varying amounts of the rabbit anti-HGH serum were allowed to interreact for 20 to 24 hours at 40 C. After this period, the precipitates were separated by centrifugation, washed twice with phosphate-saline buffer and then dissolved in 0.25 M acetic acid. The protein concentration was determined by measuring the absorbance in the Beckman spectrophotometer at 278 my (22) . On the basis of such a titration (Figure 2 ), the amount of anti-HGH serum maximally precipitated by a given amount of anti-RGG was found and the zone of antibody (i.e., anti-RGG) excess was defined.
To confirm the results of the precipitin titration, a second titration was performed employing constant amounts of HGH-131, rabbit anti-HGH serum, and varying amounts of goat anti-RGG serum. After incubation and centrifugation, aliquots of the supernatant solution were counted. A parallel titration was run for comparison, using 1 per cent human -y-globulin as the diluent to evaluate the effect of any cross reaction of the goat antisera and human -y-globulin. relation of the apparent HGH concentration and the state of pituitary function of the patient (Figure 6 ). In addition, ovine, porcine, and bovine sera inhibited the precipitation of HGH-I131 to a major extent (Figure 6 ), making it appear that these sera contained HGH.
Numbers of observations have been made to define the nonspecific inhibitor of HGH-I131 immunoprecipitation in unextracted plasma. The inhibitor is not inactivated by heating to 60°C for 60 minutes or by prolonged dialysis against water or phosphate-saline buffer. Treating the plasma with 0.01 M periodate according to the method of Burnet and Lind (23), a technique which removes the mucoprotein inhibitor of influenza hemagglutination, failed to remove the nonspecific inhibitor of HGH-I3' precipitation.
The possibility has been considered that the y-globulin of the test samples might cross react with the antirabbit y-globulin immune serum, so that there would be insufficient goat antisera to precipitate all the rabbit y-globulin present. Although cross reactivity between human y-globulin and goat anti-RGG serum does exist, as demonstrated by a precipitin zone in a double diffusion agar system, human y-globulin, when added to control assay tubes in amounts comparable to that in undiluted serum, failed to inhibit HGH-Il'3 precipitation. Furthermore, neither increasing the amount of anti-RGG serum as much as fourfold nor diluting the test serum as much as tenfold abolished the nonspecific inhibitor.
There is clear evidence that albumin does not interfere with the immunoreactions used for HGH assay, in that bovine albumin solutions are used as diluents throughout the procedure and the Gemzell extraction procedure yields a product which is almost exclusively composed of albumin.
The possibility that the nonspecific inhibitor degrades HGH-I'31 is made unlikely by two observations. First, at the completion of the immunologic reactions no increase in TCA-soluble radioactivity could be demonstrated in tubes containing serum showing nonspecific inhibition. Second, when HGH was added to unextracted serum, the increment could be measured almost quantitatively by radio-immunoassay.
Extraction of HGH from plasma. The finding that plasma from human beings and other animal species contained a nonspecific inhibitor of the radio-immunoassay prompted an examination of several methods of extracting HGH from plasma. Fortunately, the procedure of Gemzell (4) completely excluded the nonspecific inhibitor of ovine, bovine, and porcine sera ( Figure 6 ). When this method, using unconcentrated extracts, was applied to 30 plasma samples from normal adults, HGH activity was detected in 12. All plasma extracts contained less than 50 mLg of HGH even when corrected for losses incurred in the extraction procedure (Figure 7) . Extracts from plasma of 22 untreated acromegalic patients had from 15 to 260 mjug per ml, with a mean of 112 mug per ml. Included also in Figure 7 are the results of assays on plasma extracts from a few acromegalic patients after completion of radiation or surgical therapy, whose disease was considered clinically inactive. At the present level of sensitivity little or no HGH was found in the plasma of hypopituitary patients. An exception, however, was one adult patient who had had a craniotomy for craniopharyngioma and who had a serum HGH assay of 32 m~ug per ml.
DISCUSSION
The iodination of growth hormone has presented special problems. With the low concentration of hormone protein employed and the high specific activities required for millimicrogram sensitivity of the assay, instability of the labeled hormone has frequently been encountered with direct methods of iodination. It is likely that trace impurities in the original iodine solution or other reagents led to difficulty in using the methods of Yalow and Berson (11) . Most of these difficulties are obviated by the distillation technique. It has been observed that much of the degraded hormone exists as relatively small fragments which can be removed by prolonged dialysis. For this reason, the dialysis following iodination has been continued for 20 to 24 hours. Since the labeled hormone has been used solely as an analytical reagent, we have made no attempt to determine its biological activity in experimental animals, but have been content with the demonstration of its reactivity with specific antibody. It is likely that further refinements of existing methods will permit preparation of labeled hormone of higher specific activities.
The sensitivity of the assay system is dependent not only on the specific activity of the labeled growth hormone, but also on the careful adjustment of the concentrations of rabbit anti-HGH and goat anti-RGG sera. A slight excess of HGH-I131 in respect to anti-HGH must be in the system before added HGH will effectively compete for the limited number of specific binding sites on the anti-HGH serum. The limit of sensitivity of the assay to date is about 3 mpg. When and improved methods of counting are devised, greater sensitivities should be obtainable. The anti-RGG must be in excess in respect to the anti-HGH to insure precipitation of all rabbit antibodies and, therefore, of all bound HGH-I'1 .
The use of immunoprecipitation rather than chromatoelectrophoresis to separate free from bound HGH-I'31 offers certain technical advantages. Large numbers of samples can be assayed simultaneously with a series of tubes containing standard HGH dilutions, and the free HGH-I131 is easily sampled for counting after centrifugation. However, the major obstacle to the application of radio-immunoassay to the measurement of HGH in plasma has been the existence of the nonspecific inhibitor. It is recognized that the extraction procedure used is not a completely satisfactory solution to this problem because it introduces a relatively tedious operation and is subject to significant and variable losses. More information concerning the properties of the nonspecific inhibitor is needed before a simpler procedure for its removal can be designed.
The antigenic specificity of HGH has been studied and extensively described by previous workers (7, 9, 24, 25) . Our observations with radio-immunoprecipitation confirm the information obtained with more orthodox immunologic procedures showing that antisera induced in rabbits by HGH reacts only with other primate growth hormones and not with growth hormones of other species. Antisera produced by Raben human growth hormone may contain trace amounts of antibodies reacting with serum proteins (6, 9, 26, 27) . Our results confirm this general experience. A faint precipitin zone was observed when serum from a hypophysectomized patient was tested against undiluted antiserum in the highly sensitive double diffusion technique. It is doubtful whether the presence of contaminating antibodies in our antisera participated significantly in our assay system, because the concentrations of non-growth hormone antigenic proteins which might be iodinated in our preparations of growth hormone is probably very low. Only a single precipitin zone was evident in the reaction between growth hormone and antisera. Also, in both starch and paper electrophoretic studies the radioactivity of our labeled growth hormone migrated as a single component with a mobility of a-globulin. Trace contamination of the human growth hormone used for iodination would lead to significant error in our assay only if selective heavy labeling of the contaminants in preference to the hormone occurred.
The levels of circulating HGH found in normal individuals by this method have been from 0 to 50 m1ug per ml. Further improvement in the sensitivity of the assay and concentration of extracts will be required before the normal level of hormone can be accurately measured. Nevertheless, it is clear that the concentrations of HGH detected by this method are less than one-fourth those reported by Read and Bryan (9) . The reasons for this discrepancy are unknown. The possibility exists that nonspecific inhibition may operate in the hemagglutination inhibition system and contribute to difficulties with its use (10, 28) . The current lack of accord of insulin assays may be due in part to differences in the physical state of insulin in the blood (29) . Perhaps the divergent results obtained with growth hormone assays may be due to the measurement of different components of the total growth hormone activity of plasma.
SUMMARY
Methods for the radioiodination of human growth hormone which yield labeled hormone of both high specific radioactivity and reactivity with specific antibodies are described. With these preparations a radio-immunoassay for human growth hormone, capable of detecting 3 to 6 m/xg human growth hormone, has been developed.
Bovine, ovine, and porcine growth hormone did not prevent the immunoprecipitation of iodinated human growth hormone in this assay, but monkey growth hormone inhibited iodinated human growth hormone precipitation.
Human and animal sera were found to contain a nonspecific inhibitor of the immunoassay system which can be excluded by an extraction procedure that permits the extraction of growth hormone.
Circulating levels of growth hormone determined by radio-immunoassay in normal adults ranged from 0 to 50 m~ug per ml. Levels of 15 to 250 m~ug per ml were found in a series of untreated acromegalic subjects while values after treatment ranged from 0 to 27 m/Ag per ml.
